SELLAS Life Sciences (SLS) Change in Accured Expenses (2019 - 2024)
Historic Change in Accured Expenses for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $307000.0.
- SELLAS Life Sciences' Change in Accured Expenses fell 5544.27% to $307000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was -$1.4 million, marking a year-over-year decrease of 15739.72%. This contributed to the annual value of -$2.2 million for FY2024, which is 25072.46% down from last year.
- Latest data reveals that SELLAS Life Sciences reported Change in Accured Expenses of $307000.0 as of Q3 2024, which was down 5544.27% from -$1.4 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences' Change in Accured Expenses ranged from a high of $1.7 million in Q4 2022 and a low of -$1.4 million during Q2 2024
- Over the past 5 years, SELLAS Life Sciences' median Change in Accured Expenses value was $215000.0 (recorded in 2022), while the average stood at $231789.5.
- Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 271311.48% in 2022, then tumbled by 63163.27% in 2024.
- Over the past 5 years, SELLAS Life Sciences' Change in Accured Expenses (Quarter) stood at -$391000.0 in 2020, then soared by 115.6% to $61000.0 in 2021, then surged by 2713.11% to $1.7 million in 2022, then crashed by 53.03% to $806000.0 in 2023, then tumbled by 61.91% to $307000.0 in 2024.
- Its Change in Accured Expenses was $307000.0 in Q3 2024, compared to -$1.4 million in Q2 2024 and -$1.0 million in Q1 2024.